Horizon Europe. Research and Innovation Actions. Cluster 1 - Health (Single stage - 2027). Calls for proposals:

Development of cell-free protein synthesis platforms for discovery and/or production of biologicals. HORIZON-HLTH-2027-01-IND-01.
Addressing disabilities through the life course to support independent living and inclusion. HORIZON-HLTH-2027-01-STAYHLTH-01.
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change. HORIZON-HLTH-2027-01-ENVHLTH-02.
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications. HORIZON-HLTH-2027-01-CARE-02.
Tools and technologies to support health adaptation to climate change. HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03.
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential. HORIZON-HLTH-2027-01-DISEASE-05 .
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses. HORIZON-HLTH-2027-01-DISEASE-06.
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses. HORIZON-HLTH-2027-01-DISEASE-07.
Development of innovative antimicrobials against pathogens resistant to antimicrobials. HORIZON-HLTH-2027-01-DISEASE-08.
Prevention and management of chronic non-communicable diseases in children and young people (GACD). HORIZON-HLTH-2027-01-DISEASE-10.